Signalling by melatonin receptors;Signalisation des recepteurs de la melatonine

Therapie

Volumn 53, Issue 5, 1998, Pages 421-428

  Petit, L ^a,c   Guardiola, B ^b   Delagrange, P ^b   Jockers, R ^a   Strosberg, A D ^a  

^a CNRS   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c INSTITUT COCHIN   (France)

Author keywords

cGMP; Mel(1A), Mel(1B), Mel(1C) receptors; Melatonin; Signalling

Indexed keywords

ADENYLATE CYCLASE; GUANYLATE CYCLASE; MELATONIN RECEPTOR; PHOSPHOLIPASE C; POTASSIUM CHANNEL; RECEPTOR SUBTYPE; CELL RECEPTOR; CELL SURFACE RECEPTOR; CYCLIC GMP; MELATONIN;

CIRCADIAN RHYTHM; CONFERENCE PAPER; ENZYME INHIBITION; HORMONE RELEASE; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ANIMAL; DRUG ANTAGONISM; GENETICS; METABOLISM; PHYSIOLOGY; REVIEW;

ADENYLATE CYCLASE; ANIMALS; CYCLIC GMP; HUMANS; MELATONIN; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; SIGNAL TRANSDUCTION;

EID: 0032151780     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)

1. Becker-Andre M, Wiesenberg I, Schaeren WN et al. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem 1994; 269: 28531-28534.
2. Reppert SM, Weaver DR, Rivkees SA, Stopa EG. Putative melatonin receptors in a human biological clock. Science 1988; 242: 78-81.
3. Touitou Y, Bogdan A, Reinberg A, Haus E. Annual endocrine rhythms in man. Pathol Biol (Paris) 1996; 44: 654-665.
4. Maestroni G. The immunoneuroendocrine role of melatonin. J Pineal Res 1993; 14: 1-10.
5. Ying SW, Niles LP, Crocker C. Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin. Eur J Pharmacol 1993; 246: 89-96.
6. Blask D, Lemus-Wilson A, Wilson S. Breast cancer: a model system for studying the neuroendocrine role of pineal melatonin in oncology. Biochem Soc Trans 1992; 20: 309-311.
7. Reiter R, Oh C-S, Fujimori O. Melatonin, its intracellular and genomic actions. Trends Endocrinol Metab 1996; 7: 22-27.
8. Vakkuri O, Leppaluoto J, Vuolteenaho O. Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as a tracer. Acta Endocrinol 1984; 106: 152-156.
9. Dubocovich ML. Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 1995; 16: 50-54.
10. Duncan MJ, Takahashi JS, Dubocovich ML. 2-[125I]iodomelatonin binding sites in hamster brain membranes: pharmacological characteristics and regional distribution. Endocrinology 1988; 122: 1825-1833.
11. Duncan MJ, Takahashi JS, Dubocovich ML. Characteristics and autoradiographic localization of 2-[125I]iodomelatonin binding sites in Djungarian hamster brain. Endocrinology 1989; 125: 1011-1018.
12. Molinari EJ, North PC, Dubocovich ML. 2-[125I]iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites. Eur J Pharmacol 1996; 301: 159-168.
13. 1b melatonin receptor. Proc Natl Acad Sci USA 1995; 92: 8734-8738.
14. Reppert SM, Weaver DR, Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994; 13: 1177-1185.
15. Ebisawa T, Karne S, Lerner MR, Reppert SM. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci USA 1994; 91: 6133-6137.
16. Chan C, Song Y, Ailenberg M et al. Studies of melatonin effects on epithelia using the human embryonic kidney cells (HEK-293) cell line. Endocrinology 1997; 138: 4732-4739.
17. Dubocovich ML. Luzindole (N-0774): a novel melatonin receptor antagonist. J Pharmacol Exp Ther 1988; 246: 902-910.
18. Popova JS, Dubocovich ML. Melatonin receptor-mediated stimulation of phosphoinositide breakdown in chick brain slices. J Neurochem 1995; 64: 130-138.
19. Mullins UL, Eison AS. Pharmacologic characterization of melatonin-mediated phosphoinositide hydrolysis in pigeon brain. J Pineal Res 1994; 17: 33-38.
20. Mullins UL, Fernandes PB, Eison AS. Melatonin agonists induce phosphoinositide hydrolysis in Xenopus laevis melanophores. Cell Signal 1997; 9: 169-173.
21. Vanecek J, Pavlik A, Illnerova H. Hypothalamic melatonin receptor sites revealed by autoradiography. Brain Res 1987; 435: 359-362.
22. Morgan PJ, Williams LM, Davidson G. Melatonin receptors on ovine pars tuberalis: characterization and autoradiographical localization. J Neuroendocrinology 1989; 1: 1-4.
23. Weaver DR, Stehle JH, Stopa EG, Reppert SM. Melatonin receptors in human hypothalamus and pituitary: implications for circadian and reproductive responses to melatonin. J Clin Endocrinol Metab 1993; 76: 295-301.
24. Rivkees SA, Cassone VM, Weaver DR, Reppert SM. Melatonin receptors in chick brain: characterization and localization. Endocrinology 1989; 125: 363-368.
25. Mazzucchelli C, Capsoni S, Angeloni D et al. Expression of the melatonin receptor in Xenopus laevis: a comparative study between protein and mRNA distribution. J Pineal Res 1996; 20: 57-64.
26. Blazynski C, Dubocovich M. Localization of 2-(125I)Iodomelatonin binding sites in mammalian retina. J Neurochem 1991; 56: 1873-1880.
27. Dubocovich ML, Takahashi JS. Use of 2-[125I]iodomelaconin to characterize melatonin binding sites in chicken retina. Proc Natl Acad Sci USA 1987; 84: 3916-3920.
28. Pontoire C, Bernard M, Silvain C et al. Characterization of melatonin binding sites in chicken and human intestines. Eur J Pharmacol 1993; 247: 111-118.
29. Pang CS, Tang PL, Pang SF, Brown GM. Comparison of the pharmacological characteristics of 2-[125I]iodomelatonin binding sites in the lung, spleen, brain and kidney of chicken. Biol Signals 1995; 4: 311-324.
30. Pang CS, Pang SF. High affinity specific binding of 2-[125I]iodomelatonin by spleen membrane preparations of chicken. J Pineal Res 1992; 12: 167-173.
31. Rafii eI M, Calvo JR, Pozo D, Harmouch A, Guerrero JM. Specific binding of 2-[125I]iodomelatonin by rat splenocytes: characterization and its role on regulation of cyclic AMP production. J Neuroimmunol 1995; 57: 171-178.
32. Lopez GM, Martin CA, Calvo JR et al. Specific binding of 2-[125I] melatonin by partially purified membranes of rat thymus. J Neuroimmunol 1993; 45: 121-126.
33. Song Y, Tam PC, Poon AM, Brown GM, Pang SF. 2-[125I]iodomelatonin-binding sites in the human kidney and the effect of guanosine 5′-O-(3-thiotriphosphate). J Clin Endomnol Metab 1995; 80: 1560-1565.
34. Gilad E, Laudon M, Matzkin H et al. Functional melatonin receptors in human prostate epithelial cells. Endocrinology 1996; 137: 1412-1417.
35. Gonzalez HM, Garcia MS, Calvo JR et al. High-affinity binding of melatonin by human circulating T lymphocytes (CD4+). Faseb J 1995; 9: 1331-1335.
36. Lopez GM, Calvo JR, Segura JJ, Guerrero JM. Characterization of melatonin binding sites in human peripheral blood neutrophils. Biotechnol Ther 1993; 4: 253-262.
37. Pickering DS, Niles LP. Expression of nanomolar-affinity binding sites for melatonin in Syrian hamster RPMI 1846 melanoma cells. Cell Signal 1992; 4: 201-207.
38. Le Gouic S, Delagrange P, Atgie C et al. Effects of both a melatonin agonist and antagonist on seasonal changes in body mass and energy intake in the garden dormouse. Int J Obesity 1996; 20: 661-667.
39. Le Gouic S, Atgie, C., Viguerie, N et al. 18me réunion scientifique Groupe biologie du développement, 'développement du tissu adipeux: Génétique et Nutriments', (Toulouse) 1996.
40. Reppert SM, Weaver DR, Cassone VM, Godson C, Kolakowski LJ. Melatonin receptors are for the birds: molecular analysis of two receptor subtypes differentially expressed in chick brain. Neuron 1995; 15: 1003-1015.
41. Reppert SM, Weaver DR, Godson C. Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol Sci 1996; 17: 100-102.
42. Jockers R, Petit L, Lacroix I et al. Novel isoforms of Mel1c melatonin receptor modulating intracellular cyclic guanosine 3′,5′-monophosphate levels. Mol Endocrinol 1997; 11: 1070-1081.
43. 1a melatonin receptor. Biochem Biophys Acta 1997; 1356, 3: 299-307.
44. Mazzucchelli C, Pannacci, M., Nonno, R. et al. The melatonin receptor in the human brain: cloning experiments and distribution studies. Mol Brain Res 1996; 39: 117-126.
45. 1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol 1997; 355: 365-375.
46. Morgan P, Lawson W, Davidson G, Howell H. Melatonin inhibits cyclic AMP in cultured ovine pars tuberalis cells. J Mol Endocrinol 1989; 3: R5-R8.
47. Rollag M. Response of amphibian melanophores to melatonin. Pineal Res Rev 1988; 6: 67-93.
48. Morgan P, Barret P, Howell H, Helliwel R. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 1994; 24: 101-146.
49. Vanececk J, Vollrath L. Melatonin inhibits cAMP and cGMP in the rat pituitary. Brain Res 1989; 505, 1: 157-159.
50. Gilad E, Matzkin H, Zisapel N. Inactivation of melatonin receptors by protein kinase C by human prostate epithelial cells. Endocrinology 1997; 138: 4255-4261.
51. Garthwaite J, Southam E, Boulton C et al. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-(1,2,4)ox-adiazolo(4,3-a)quinoxalin-1-one. Mol Pharmacol 1995; 48: 184-188.
52. 1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 1997; 138: 397-404.
53. Liu C, Weaver DR, Jin X et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic arcadian clock. Neuron 1997; 19: 91-102.
54. Jiang Z, Nelson C, Allen C. Melatonin activates an outward current and inhibits 1h in rat suprachiasmatic nucleus neurons. Brain Res 1995; 687: 125-132.
55. Nelson CS, Marino JL, Allen CN. Melatonin receptors activate heteromeric G-protein coupled Kir3 channels. Neuroreport 1996; 7: 717-720.